Assessment of changes in carbohydrate metabolism parameters in rats with experimental diabetes mellitus of different origins under L-arginine and N-acetyl-L-cysteine administration
DOI:
https://doi.org/10.14739/2310-1237.2025.2.337017Keywords:
type 1 and 2 diabetes mellitus, insulin, HOMA-IR and HOMA-β indices, L-arginine, N-acetyl-L-cysteine, correlation analysis, ratsAbstract
The aim: to determine the specificity of changes in carbohydrate metabolism in rats with experimental type 1 (DM1) and type 2 (DM2) diabetes mellitus and to analyze correlations of their modification under administration of the amino acids L-arginine and N-acetyl-L-cysteine.
Materials and methods. DM1 was induced in old male Wistar rats by a single 45 mg/kg streptozotocin. In rats with DM2, insulin resistance was first induced (high-fat mixed feed for 8 weeks), after which 30 mg/kg streptozotocin was administered once. After 6 weeks, animals with DM were divided into 3 subgroups: without amino acid administration, rats with L-arginine and with N-acetyl-L-cysteine.
Results. Experimental modeling of DM1 resulted in persistent hyperglycemia and hypoinsulinemia, which significantly altered metabolic indices. In rats with DM2, hyperglycemia developed with hyperinsulinemia, indicating established insulin resistance. Administration of L-arginine and N-acetyl-L-cysteine to rats with both types of diabetes lowered glucose levels and increased insulin concentrations, although no statistically significant difference was found between the effects of these amino acids. L-arginine significantly increased the HOMA-β index in rats with DM1 and moderately increased it in rats with DM2. In addition, it caused a significant increase in the HOMA-IR index in the group with DM1, indicating improved insulin sensitivity. N-acetyl-L-cysteine also improved HOMA-β and HOMA-IR indices in rats with DM1, although its effect on DM2 was less pronounced and did not reach statistical significance.
Conclusions. In rats with type 1 diabetes, both amino acids cause a decrease in glucose concentration, which is due to improved pancreatic β-cell function due to increased insulin concentration, the HOMA-β index compared to the subgroup without correction, but also causes an increase in the HOMA-IR index, and the listed indicators do not return to control values. These changes were accompanied by profound disruption of metabolic relationships, which is confirmed by correlation analysis. Against the background of the development of type 2 diabetes mellitus, both amino acids reduce glucose concentration and increase insulin compared to the subgroup without correction, however, the HOMA-β index improves only in rats with L-arginine, and the preserved hyperinsulinemia in all 3 subgroups leads to an increase, compared to the control, in the HOMA-IR index without a significant difference between the effects of amino acids. Correlation analysis revealed greater preservation of metabolic relationships of carbohydrate metabolism indicators compared to rats with type 1 diabetes mellitus.
References
Martin SS, Aday AW, Almarzooq ZI, Anderson CA, Arora P, Avery CL, et al. 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. 2024;149(8):e347-e913. doi: https://doi.org/10.1161/CIR.0000000000001209. Erratum in: Circulation. 2024;149(19):e1164. doi: https://doi.org/10.1161/CIR.0000000000001247. Erratum in: Circulation. 2025;151(25):e1095. doi: https://doi.org/10.1161/CIR.0000000000001344
Urgent action needed as global diabetes cases increase four-fold over past decades [Internet]. Who.int. [cited 2025 Jun 25]. Available from: https://www.who.int/news/item/13-11-2024-urgent-action-needed-as-global-diabetes-cases-increase-four-fold-over-past-decades
Cloete L. Diabetes mellitus: an overview of the types, symptoms, complications and management. Nurs Stand. 2022;37(1):61-6. doi: https://doi.org/10.7748/ns.2021.e11709
Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Lernmark Å, et al. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Diabetes Care. 2023;46(10):e151-99. doi: https://doi.org/10.2337/dci23-0036
Liu Y, Wang H, Liang Y, Guo Z, Qu L, Wang Y, et al. Dietary intakes of methionine, threonine, lysine, arginine and histidine increased risk of type 2 diabetes in Chinese population: does the mediation effect of obesity exist? BMC Public Health. 2023;23(1):1551. doi: https://doi.org/10.1186/s12889-023-16468-z
Bajwa NS, Aslam MW, Amin MR ul, Abida Mateen A, Saifullah Khan, Ain Q ul, et al. Comparative Study of Metformin, N-Acetylcysteine and L-Arginine on Hyperglycemia in Streptozotocin-Induced Diabetic Rats. Pakistan Journal of Medical and Health Sciences. 2022;16(02):508-11. doi: https://doi.org/10.53350/pjmhs22162508
Forzano I, Avvisato R, Varzideh F, Jankauskas SS, Cioppa A, Mone P, et al. L-Arginine in diabetes: clinical and preclinical evidence. Cardiovasc Diabetol. 2023;22(1):89. doi: https://doi.org/10.1186/s12933-023-01827-2. Erratum in: Cardiovasc Diabetol. 2023;22(1):117. doi: https://doi.org/10.1186/s12933-023-01852-1
Popazova O, Belenichev I, Bukhtiyarova N, Ryzhenko V, Gorchakova N, Oksenych V, et al. Molecular and Biochemical Mechanisms of Cardiomyopathy Development Following Prenatal Hypoxia-Focus on the NO System. Antioxidants (Basel). 2025;14(6):743. doi: https://doi.org/10.3390/antiox14060743
Xing S, Guo Z, Lang J, Zhou M, Cao J, He H, et al. N-Acetyl-l-cysteine ameliorates gestational diabetes mellitus by inhibiting oxidative stress. Gynecol Endocrinol. 2023;39(1):2189969. doi: https://doi.org/10.1080/09513590.2023.2189969
European Union. Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. Official Journal of the European Union, L276/33, 2010.
Verkhovna Rada of Ukraine. On the Protection of Animals from Brutal Treatment. Law of Ukraine; February 21, 2006 No. 3447-IV. Available from: https://zakon.rada.gov.ua/go/3447-15
Kolesnyk YM, Isachenko MI. [Analysis of the body composition of rats with experimental diabetes mellitus type 1 and its correction]. Modern medical technology. 2024;16(4):247-54. Ukrainian. doi: https://doi.org/10.14739/mmt.2024.4.311425
Kolesnyk YM, Isachenko MI. [Modeling insulin resistance in Wistar rats induced by a combined high-fat diet as a predictor of type 2 diabetes (experimental phase 1 study)]. Pathologia. 2025;22(1):5-11. Ukrainian. doi: https://doi.org/10.14739/2310-1237.2025.1.314277
Halperin F, Mezza T, Li P, Shirakawa J, Kulkarni RN, Goldfine AB. Insulin regulates arginine-stimulated insulin secretion in humans. Metabolism. 2022;128:155117. doi: https://doi.org/10.1016/j.metabol.2021.155117
Cho J, Horikawa Y, Enya M, Takeda J, Imai Y, Imai Y, et al. L-Arginine prevents cereblon-mediated ubiquitination of glucokinase and stimulates glucose-6-phosphate production in pancreatic β-cells. Commun Biol. 2020 Sep 8;3(1):497. doi: https://doi.org/10.1038/s42003-020-01226-3
Schuurman M, Wallace M, Sahi G, Barillaro M, Zhang S, Rahman M, et al. N-acetyl-L-cysteine treatment reduces beta-cell oxidative stress and pancreatic stellate cell activity in a high fat diet-induced diabetic mouse model. Front Endocrinol (Lausanne). 2022;13:938680. doi: https://doi.org/10.3389/fendo.2022.938680
Hosseinkhani S, Arjmand B, Dilmaghani-Marand A, Mohammadi Fateh S, Dehghanbanadaki H, Najjar N, et al. Targeted metabolomics analysis of amino acids and acylcarnitines as risk markers for diabetes by LC-MS/MS technique. Sci Rep. 2022;12(1):8418. doi: https://doi.org/10.1038/s41598-022-11970-7
Apostolopoulou M, Lambadiari V, Roden M, Dimitriadis GD. Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance. Endocr Rev. 2025;46(3):317-48. doi: https://doi.org/10.1210/endrev/bnae032
White PJ, McGarrah RW, Herman MA, Bain JR, Shah SH, Newgard CB. Insulin action, type 2 diabetes, and branched-chain amino acids: A two-way street. Mol Metab. 2021;52:101261. doi: https://doi.org/10.1016/j.molmet.2021.101261
Khalili D, Khayamzadeh M, Kohansal K, Ahanchi NS, Hasheminia M, Hadaegh F, et al. Are HOMA-IR and HOMA-B good predictors for diabetes and pre-diabetes subtypes? BMC Endocr Disord. 2023;23(1):39. doi: https://doi.org/10.1186/s12902-023-01291-9
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 M. I. Isachenko, Yu. M. Kolesnyk
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
